Effect of pioglitazone on muscle strength in streptozotocin induced diabetic mice

S. Arora, S. K. Ojha, D. Vohora

Research output: Contribution to journalArticlepeer-review


The present study was designed to investigate the effect of pioglitazone on muscle strength, a major component of physical performance as assessed by grip strength test in streptozotocin-induced diabetic mice. Pioglitazone is a peroxisome proliferator activated receptor agonist acts as an insulin sensitizer. Swiss albino mice of either sex were intraperitoneally administered multiple low dose of streptozotocin for five days to produce diabetes mellitus. Three weeks after diabetes mellitus establishment in mice, pioglitazone 20 mg/kg was administered orally for four consecutive days. Grip strength test was assessed at baseline, after diabetes induction and after pioglitazone treatment. Pioglitazone treatment improved the muscle strength in diabetic mice as evidenced by a distinct increase in grip strength and enhancement in locomotor activity. The suggested mechanism for pioglitazone treatment associated improvement in grip strength is probably due to increase in insulin sensitivity at skeletal muscles thereby correction of blood glucose levels.

Original languageEnglish
Pages (from-to)757-760
Number of pages4
JournalIndian Drugs
Issue number10
Publication statusPublished - Oct 2007
Externally publishedYes


  • Diabetes
  • Grip strength test
  • Pioglitazone
  • Streptozotocin

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery


Dive into the research topics of 'Effect of pioglitazone on muscle strength in streptozotocin induced diabetic mice'. Together they form a unique fingerprint.

Cite this